We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MANU:NYSEManchester analysis

Data as of Sep 30, 2026 - not real-time

Latest price
$20.81
Risk: medium
5/10Medium risk

Summary

Manchester United plc trades at $20.81, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 10.6%. With RSI at 47.5 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $19.05 and resistance at $21.80.
Multiples put this in overvalued territory: 141.5 times earnings against the sector's 15.4. Analyst price targets sit 10.1% above the current price. Revenue is contracting at 4.1% on a -6.3% profit margin.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 25.5%, a beta of 0.72 and a maximum drawdown of 18.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 7/10 long-term conviction.

Top market events

  • MANCHESTER, England, September 09, 2026--Manchester United plc NYSE: MANU , announces that it will report results for...
  • Manchester United stock reported fiscal 2026 revenue of GBP 677.
  • MarketScreener6d MANU Manchester United Expects Fiscal 2027 Revenue Range 740M British Pounds to 760M Pounds, vs.

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Trading above the 200-day average of 19.37
  • MACD momentum is positive
  • 30-day price change of -10.6%

Medium term

1–3 years

Cautious

Model confidence4/104 out of 10

Key factors

  • P/E of 141.5 versus sector average of 15.4
  • Trading above the 200-day average of 19.37
  • Analyst targets imply +10.1% versus the current price

Long term

> 3 years

Cautious

Model confidence7/107 out of 10

Key factors

  • P/E of 141.5 versus sector average of 15.4
  • Negative profit margin of -6.3%
  • Analyst targets imply +10.1% versus the current price

Key metrics

Financial health

Revenue Growth-4.10%
Profit Margin-6.34%
P/E Ratio141.5
ROE-24.97%
ROA-0.95%
Debt/Equity460.37
P/B Ratio14.8
Op. Cash Flow$178.7M
Free Cash Flow$-49682376
Industry P/E15.4

Technical analysis

TrendNeutral
RSI47.5
Support$19.05
Resistance$21.80
MA 20$20.46
MA 50$21.92
MA 200$19.37
MACDBullish
VolumeStable
Fear & Greed Index92.79

Valuation

Fair Value$5.01
Target Price$22.91
Upside/Downside10.07%
GradeOvervalued
TypeGrowth

Risk assessment

Beta0.72
Volatility25.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.